Literature DB >> 3232700

Fechtner syndrome: clinical and genetic aspects.

R Gershoni-Baruch1, Y Baruch, A Viener, C Lichtig.   

Abstract

Fechtner syndrome, a variant of Alport syndrome, was first reported by Peterson et al. [1985]. It is characterized by nephritis, hearing loss, eye abnormalities, macrothrombocytopenia, and leucocyte inclusions, present in varying combinations in several members of the same family. This is the second family reported; 16 relatives are affected. The clinical manifestations of the syndrome are delineated. The pattern of inheritance is autosomal dominant. The hematologic abnormalities are similar to those detected in May Hegglin anomaly. They are present in every affected relative and may be present at birth. The feasibility of prenatal diagnosis is discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3232700     DOI: 10.1002/ajmg.1320310213

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.

Authors:  J A Martignetti; K E Heath; J Harris; N Bizzaro; A Savoia; C L Balduini; R J Desnick
Journal:  Am J Hum Genet       Date:  2000-03-17       Impact factor: 11.025

Review 2.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

3.  Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.

Authors:  A Toren; N Amariglio; G Rozenfeld-Granot; A J Simon; F Brok-Simoni; E Pras; G Rechavi
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

4.  Muscular hypertrophy of the oesophagus and "Alport-like" glomerular lesions in a boy.

Authors:  E Legius; W Proesmans; B Van Damme; K Geboes; T Lerut; E Eggermont
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

5.  Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

Authors:  Alessandro Pecci; Ginevra Biino; Tiziana Fierro; Valeria Bozzi; Annamaria Mezzasoma; Patrizia Noris; Ugo Ramenghi; Giuseppe Loffredo; Fabrizio Fabris; Stefania Momi; Umberto Magrini; Mario Pirastu; Anna Savoia; Carlo Balduini; Paolo Gresele
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.